A recent post on Ars Technica explains how researchers are converting adult stem cells from patients with certain diseases into embryonic stem cells. This will hopefully make studying the cellular basis of diseases like Parkinson’s easier by providing a virtually unlimited supply of tissue, which was previously difficult to come by. This technique was developed for ALS, and it’s been applied to 10 new diseases.
The full list of diseases represented: adenosine deaminase deﬁciency-related severe combined immunodeficiency (ADA-SCID), Shwachman-Bodian-Diamond syndrome (SBDS), Gaucher disease (GD) type III, Duchenne (DMD) and Becker muscular dystrophy (BMD), Parkinson disease (PD), Huntington disease (HD), juvenile-onset, type 1 diabetes mellitus (JDM), Down syndrome (DS)/trisomy 21, and the carrier state of Lesch-Nyhan syndrome.
Sound like a list of diseases we studied in class, anyone?